Advertisement

Response to Apóstolos et al.’s (2018) “Gender Identity and Sexual Function in 46,XX Patients with Congenital Adrenal Hyperplasia Raised as Males”

  • Hee Jin KimEmail author
Letter to the Editor

The article by Apóstolos et al. (2018) titled “Gender Identity and Sexual Function in 46,XX Patients with Congenital Adrenal Hyperplasia (CAH) Raised as Males” evaluated gender identity and sexual function in four 46,XX severely virilized patients with (CAH), who were originally registered and raised as males. All four patients had male gender identity and adapted well to the assigned male gender with satisfactory sexual function. It was concluded that additional studies are desirable to support a revision of gender assignment policies in 46,XX newborns with CAH and high degrees of genital virilization. There is a controversy over gender assignment on 46,XX CAH and complete virilization (Speiser et al., 2018). Prospective studies designed to examine the long-term outcomes of gender assignment in these patients are needed. In the meantime, a systemic review of long-term follow-up data in 46,XX CAH patients using databases, and investigation through international registry or research...

Notes

Compliance with Ethical Standards

Conflict of interest

The author declares that she has no conflict of interest.

Informed Consent

Informed consent for publication was obtained from the patient.

References

  1. Apóstolos, R. A. C., Canguçu-Campinho, A. K., Lago, R., Costa, A. C. S., Oliveira, L. M. B., Toralles, M. B., & Barroso, U., Jr. (2018). Gender identity and sexual function in 46,XX patients with congenital adrenal hyperplasia raised as males. Archives of Sexual Behavior, 47, 2491–2496.CrossRefGoogle Scholar
  2. de Vries, A. L. C., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2007). Disorders of sex development and gender identity outcome in adolescence and adulthood: Understanding gender identity development and its clinical implications. Pediatric Endocrinology Reviews, 4, 343–351.PubMedGoogle Scholar
  3. Dessens, A. B., Slijper, F. M., & Drop, S. L. (2005). Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Archives of Sexual Behavior, 34, 389–397.CrossRefGoogle Scholar
  4. Fisher, A. D., Ristori, J., Fanni, E., Castellini, G., Forti, G., & Maggi, M. (2016). Gender identity, gender assignment and reassignment in individuals with disorders of sex development: A major of dilemma. Journal of Endocrinological Investigation, 39, 1207–1224.CrossRefGoogle Scholar
  5. Houk, C. P., & Lee, P. A. (2010). Approach to assigning gender in 46,XX congenital adrenal hyperplasia with male external genitalia: Replacing dogmatism with pragmatism. Journal of Clinical Endocrinology and Metabolism, 95, 4501–4508.CrossRefGoogle Scholar
  6. Hughes, I. A., Houk, C., Ahmed, S. F., Lee, P. A., & Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group. (2006). Consensus statement on management of intersex disorders. Archives of Disease in Childhood, 91, 554–564.CrossRefGoogle Scholar
  7. Khattab, A., Yau, M., Qamar, A., Gangishetti, P., Barhen, A., Al-Malki, S., … New, M. I. (2017). Long term outcomes in 46,XX adult patients with congenital adrenal hyperplasia reared as males. Journal of Steroid Biochemistry and Molecular Biology, 165, 12–17.CrossRefGoogle Scholar
  8. Lee, P. A., Houk, C. P., & Husmann, D. A. (2010). Should male gender assignment be considered in the markedly virilized patient with 46,XX and congenital adrenal hyperplasia? Journal of Urology, 184, 1786–1792.CrossRefGoogle Scholar
  9. Martin, C. L., Ruble, D. N., & Szkrybalo, J. (2002). Cognitive theories of early gender development. Psychological Bulletin, 128, 903–933.CrossRefGoogle Scholar
  10. Meyer-Bahlburg, H. F. L., Gruen, R. S., New, M. I., Bell, J. J., Morishima, A., Shimshi, M., … Baker, S. W. (1996). Gender change from female to male in classical congenital adrenal hyperplasia. Hormones and Behavior, 30, 319–332.CrossRefGoogle Scholar
  11. Nimkarn, S., Lin-Su, K., & New, M. I. (2011). Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Pediatric Clinics of North America, 58, 1281–1300.CrossRefGoogle Scholar
  12. Pasterski, V., Zucker, K. J., Hindmarsh, P. C., Hughes, I. A., Acerini, C., Spencer, D., … Hines, M. (2015). Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: Results from a standardized assessment of 4- to 11-year-old children. Archives of Sexual Behavior, 44, 1363–1375.CrossRefGoogle Scholar
  13. Schoer, M. B., Nguyen, P. N., Merritt, D. F., Wesevich, V. G., & Hollander, A. S. (2018). The role of patient advocacy and the declining rate of clitoroplasty in 46,XX patients with congenital adrenal hyperplasia. Clinical Pediatrics, 57, 1664–1671.CrossRefGoogle Scholar
  14. Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., … White, P. C. (2018). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 103, 4043–4088.CrossRefGoogle Scholar
  15. Yang, J. H., Baskin, L. S., & DiSandro, M. (2010). Gender identity in disorders of sex development: Review article. Urology, 75, 153–159.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal MedicineDankook University College of MedicineCheonan-siRepublic of Korea

Personalised recommendations